Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review

References

• Farmanfarma KK, Mahdavifar N, Mohammadian-Hafshejani A, Salehiniya H. Testicular cancer in the world: an epidemiological review. WCRJ. 2018;5(4):e1180.
   Google Scholar
• Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27. doi:10.1158/1055-9965.EPI-15-0578
   PubMed Web of Science ®Google Scholar
• Dehdari T, Dehdari L, Jazayeri S. Diet-related stomach cancer behavior among iranian college students: a text messaging intervention. Asian Pac J Cancer Prev. 2016;17(12):5165–5172.
   Google Scholar
• Akhavan A, Binesh F, Seifaddiny A. Results of combination chemotherapy and radiation therapy in non-metastatic gastric cancer in Yazd–Iran. Indian J Cancer. 2015;52(1):40–43. doi:10.4103/0019-509X.175583
   Web of Science ®Google Scholar
• Movahedi M, Afsharfard A, Moradi A, et al. Survival rate of gastric cancer in Iran. J Res Med Sci. 2009;14(6):367–373.
   PubMed Web of Science ®Google Scholar
• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
   PubMed Web of Science ®Google Scholar
• Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–362. doi:10.3748/wjg.v12.i3.354
   PubMed Web of Science ®Google Scholar
• Khazaei S, Rezaeian S, Soheylizad M, Khazaei S, Biderafsh A. Global incidence and mortality rates of stomach cancer and the human development index: an ecological study. Asian Pac J Cancer Prev. 2016;17(4):1701–1704. doi:10.7314/APJCP.2016.17.4.1701
   Google Scholar
• Mehrabani D, Hosseini SV, Rezaianzadeh A, Amini M, Mehrabani G, Tarrahi MJ. Prevalence of stomach cancer in Shiraz, Southern Iran. J ResMed Sci. 2013;18(4):335–337.
   Google Scholar
• Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pac J Cancer Prev. 2008;9(2):317–321.
   Google Scholar
• Pourhoseingholi M, Moghimi-Dehkordi B, Safaee A, Hajizadeh E, Solhpour A, Zali M. Prognostic factors in gastric cancer using log-normal censored regression model. Indian J Med Res. 2009;129(3):262–267.
   Web of Science ®Google Scholar
• Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52.
   Google Scholar
• Mohammadian M, Mahdavifar N, Salehiniya H. Trend of incidence of gastric cancer in sistan and Baluchestan province, Iran. Asian J Pharm Clin Res. 2016;9:230–233. doi:10.22159/ajpcr.2016.v9s3.14738
   Google Scholar
• Yasemi M, Ahmadi MRH, Peyman H, Yasemi MR, Khajavikhan J, Hemati K. A 7-years retrospective study of gastrointestinal cancers incidence in the Western Iran. J Clin Diagn Res. 2015;9(7):EC01.
   Google Scholar
• Rastaghi S, Jafari-Koshki T, Mahaki B, Bashiri Y, Mehrabani K, Soleimani A. Trends and risk factors of gastric cancer in Iran (2005–2010). Int J Prev Med. 2019;10:79. doi:10.4103/ijpvm.IJPVM_188_17
   Web of Science ®Google Scholar
• Sadjadi A, Derakhshan MH, Yazdanbod A, et al. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer Res. 2014;134(1):181–188. doi:10.1002/ijc.28344
   Web of Science ®Google Scholar
• Salehiniya H, Dashdebi SG, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M. Time trend analysis of cancer incidence in caspian sea, 2004–2009: a population-based cancer registries study (northern Iran). Caspian J Intern Med. 2016;7(1):25–30.
   PubMedGoogle Scholar
• Ferro A, Peleteiro B, Malvezzi M, et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7):1330–1344. doi:10.1016/j.ejca.2014.01.029
   PubMed Web of Science ®Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. doi:10.1016/j.ejca.2012.12.027
   PubMed Web of Science ®Google Scholar
• Amani F, Sadrkabir M, Sadeghieh Ahari S, et al. Epidemiology of Gastric Cancer in Northwest Iran: 2003-2011. Middle East J Cancer. 2015;6(3):189–193.
   Google Scholar
• Ajdarkosh H, Sohrabi M, Moradniani M, et al. Prevalence of gastric precancerous lesions among chronic dyspeptic patients and related common risk factors. Eur J Cancer Prev. 2015;24(5):400–406. doi:10.1097/CEJ.0000000000000118
   Web of Science ®Google Scholar
• Malekzadeh R, Sotoudeh M, Derakhshan M, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57(1):37–42. doi:10.1136/jcp.57.1.37
   PubMed Web of Science ®Google Scholar
• Khoshdel AR, Ziaei M, Ghaffari HR, Azadi S, Alimohamadi Y. The prediction number of new cases and death of gastric cancer among iranian military community during 2007-2019. Multidisciplinary Cancer Investigation. 2018;2(2):14–19.
   Google Scholar
• Rajaiefard A, Moghimi B, Tabatabaie SH, Safaie A, Tabeie SZ. Epidemiological and clinical features of gastric cancer: descriptive study of cancer registry cases of Fars province (2001–2006). ISMJ. 2011;14(2):114–121.
   Google Scholar
• Rahimi F, Heidari M. Time trend analysis of stomach cancer incidence in the west of Iran. Health and Development Journal. 2012;1(2):100.
   Google Scholar
• Zendehdel N. Nasseri‐Moghaddam S, Malekzadeh R, et al. Helicobacter Pylori Reinfection Rate 3 Years After Successful Eradication. J Gastroenterol Hepatol. 2005;20(3):401–404.
   Web of Science ®Google Scholar
• Keramati MR, Sadeghian MH, Ayatollahi H, Badiee Z, Shakibayi H, Moghimi-Roudi A. Role of the Lewis and ABO blood group antigens in Helicobacter pylori Infection. MJMS. 2012;19(3):17.
   Google Scholar
• Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14(4):302–308.
   PubMed Web of Science ®Google Scholar
• Alborzi A, Soltani J, Pourabbas B, et al. Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn Microbiol Infect Dis. 2006;54(4):259–261. doi:10.1016/j.diagmicrobio.2005.10.012
   Web of Science ®Google Scholar
• Sung N, Choi K, Park E, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer. 2007;97(5):700–704. doi:10.1038/sj.bjc.6603893
   PubMed Web of Science ®Google Scholar
• Mohagheghi S, Mousavi JS, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998–2001. Arch Iran Med. 2009;12(1):15–23.
   PubMed Web of Science ®Google Scholar
• Naghibzadeh TA, Khanjani N, Yazdi FV, Varzandeh M, HAGHDOOST AA. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Arch Iran Med. 2014;17(1):2–6.
   Web of Science ®Google Scholar
• Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci. 2005;5(2):380–382. doi:10.3923/jas.2005.380.382
   Google Scholar
• Nakhaee N, Divsalar K, Meimandi MS, Dabiri S. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Subst Use Misuse. 2008;43(3–4):513–520.
   PubMed Web of Science ®Google Scholar
• Mamtani R, Cheema S, Sheikh J, Al Mulla A, Lowenfels A, Maisonneuve P. Cancer risk in waterpipe smokers: a meta-analysis. Int J Public Health. 2017;62(1):73–83. doi:10.1007/s00038-016-0856-2
   PubMed Web of Science ®Google Scholar
• Daneshi-Maskooni M, Badri-Fariman M, Habibi N, et al. The relationship between food insecurity and esophageal and gastric cancers: a case-control study. JRes Health Sci. 2017;17(2):e00381.
   Google Scholar
• Dorosty AR. Food insecurity and chronic diseases: the editorial. Nutri Food Sci Res. 2016;3(3):1–2. doi:10.18869/acadpub.nfsr.3.3.1
   Google Scholar
• Kaiser LL, Townsend MS, Melgar-Quiñonez HR, Fujii ML, Crawford PB. Choice of instrument influences relations between food insecurity and obesity in Latino women. Am J Clin Nutr. 2004;80(5):1372–1378. doi:10.1093/ajcn/80.5.1372
   PubMed Web of Science ®Google Scholar
• Rose D, Gundersen C, Oliveira V Socio-economic determinants of food insecurity in the United States: Evidence from the SIPP and CSFII datasets. 1998.
   Google Scholar
• Poorolajal J. Resistance economy and new population policy in Iran. JRHS. 2017;17:1.
   Google Scholar
• Lee W-J, Hong R-L, Lai I-R, Chen C-N, Lee P-H, Huang M-T. Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer. J Clin Gastroenterol. 2003;36(1):30–33. doi:10.1097/00004836-200301000-00010
   Web of Science ®Google Scholar
• Etemadi M, Pourian M, Shakib A, Sabokbar T, Peyghanbari V, Shirkoohi R. A registry program for familial gastric cancer patients referred to Cancer Institute of Iran. Asian Pac J Cancer Prev. 2014;15(5):2141–2144. doi:10.7314/APJCP.2014.15.5.2141
   Google Scholar
• Safaee A, Moghimi-Dehkordi B, Fatemi SR, Maserat E, Zali MR. Association of stomach cancer risk in individuals with family history of cancer. Koomesh. 2012;13(2):264–268.
   Google Scholar
• Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Cancer Epidemiol. 2009;467–477.
   Google Scholar
• Keramati MR, Shakibaei H, Kheiyyami MI, et al. Blood group antigens frequencies in the northeast of Iran. Transfus Apher Sci. 2011;45(2):133–136. doi:10.1016/j.transci.2011.07.006
   Web of Science ®Google Scholar
• Msc EF, Msc MRS. Prevalence and characteristics of Epstein-Barr virus-associated gastric cancer in Iran. Arch Iran Med. 2014;17(11):767.
   Web of Science ®Google Scholar
• Amoueian S, Attaranzadeh A, Gholamimoallem Z, Sadeghi M, Hashemi S-M, Allahyari A. Epstein-Barr virus infection in adult patients with gastric cancer in Northeast of Iran. Indian J Med Paediatr Oncol. 2018;39(2):206–209. doi:10.4103/ijmpo.ijmpo_132_17
   Web of Science ®Google Scholar
• Arvin A, Campadelli-Fiume G, Mocarski E, et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press; 2007.
   Google Scholar
• Camargo MC, Kim W-H, Chiaravalli AM, et al. Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236–243. doi:10.1136/gutjnl-2013-304531
   PubMed Web of Science ®Google Scholar
• Tahaei S, Mohebbi SR, Fatemi SR, et al. Low frequency of human T-cell lymphotropic virus 1 antibodies in Iranian gastric cancer patients in comparison to controls. Asian Pac J Cancer Prev. 2011;12:2447–2450.
   Google Scholar
• Farmanfarma KK, Mohammadian M, Shahabinia Z, Hassanipour S, Salehiniya H. Brain cancer in the world: an epidemiological review. W C R J. 2019;6:5.
   Google Scholar
• Farma KKF, Jalili Z, Zareban I, Pour MS. Effect of education on preventive behaviors of breast cancer in female teachers of guidance schools of Zahedan city based on health belief model. J Educ Health Promot. 2014;3:77.
   Google Scholar
• Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran—a population based study. Int J Cancer. 2009;125(8):1953–1960. doi:10.1002/ijc.24499
   PubMed Web of Science ®Google Scholar
• Drake IM, Davies MJ, Mapstone NP, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis. 1996;17(3):559–562. doi:10.1093/carcin/17.3.559
   Web of Science ®Google Scholar
• Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer. 2004;7(1):46–53. doi:10.1007/s10120-004-0268-5
   PubMedGoogle Scholar
• Mashhadi M, Nazem K, Abdollahinejad M. Gastric cancer in south East of Iran. Int J Hematol Oncol Stem Cell Res. 2009;3(4):38–42.
   Google Scholar
• Takenaka S, Sera N, Tokiwa H, Hirohata I, Hirohata T. Identification of mutagens in Japanese pickles. Mutation Research/Genetic Toxicology. 1989;223(1):35–40. doi:10.1016/0165-1218(89)90060-8
   Web of Science ®Google Scholar
• Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009;12(6):576–583.
   PubMed Web of Science ®Google Scholar
• Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol. 2007;102(8):1789. doi:10.1111/j.1572-0241.2007.01335.x
   PubMed Web of Science ®Google Scholar
• Pakseresht M, Forman D, Malekzadeh R, et al. Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control. 2011;22(5):725–736. doi:10.1007/s10552-011-9744-5
   PubMed Web of Science ®Google Scholar
• Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomedicine. 2001;55(6):333–339.
   Google Scholar
• Kavousi A, Bashiri Y, Mehrabi Y, Etemad K. Modeling high-risk areas for gastric cancer in men and women, 2005-2009. J Isfahan Med Sch. 2015;33(322):82–92.
   Google Scholar
• Moghimi-Dehkordi B, Safaee A, Fatemi R, Ghiasi S, Zali MR. Impact of age on prognosis in Iranian patients with gastric carcinoma: review of 742 cases. Asian Pac J Cancer Prev. 2010;11(2):33–38.
   Google Scholar
• Mikaeli J, Islami F, Mehrabi N, Elahi E, Malekzadeh R. Achalasia: a review of Western and Iranian Experiences and Studies. GOVARESH. 2010;15(2):116–128.
   Google Scholar
• Behnampour N, Hajizadeh E, Zayeri F, Semnani S. Modeling of influential predictors of gastric cancer incidence rates in Golestan Province, North Iran. Asian Pac J Cancer Prev. 2014;15(3):1111–1117. doi:10.7314/APJCP.2014.15.3.1111
   PubMedGoogle Scholar
• Yassibas E, Arslan P, Yalcin S. Evaluation of dietary and life-style habits of patients with gastric cancer: a case-control study in Turkey. Asian Pac J Cancer Prev. 2012;13(5):2291–2297. doi:10.7314/APJCP.2012.13.5.2291
   PubMedGoogle Scholar
• Azarbarzin S, Feizi MAH, Safaralizadeh R, et al. The value of miR-299-5p in diagnosis and prognosis of intestinal-type gastric adenocarcinoma. Biochem Genet. 2016;54(4):413–420. doi:10.1007/s10528-016-9728-y
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–114. doi:10.1038/nrg2290
   PubMed Web of Science ®Google Scholar
• Day AS, Su B, Ceponis PJ, et al. Helicobacter pylori infection induces interleukin-18 production in gastric epithelial (AGS) cells. Dig Dis Sci. 2004;49(11–12):1830–1835. doi:10.1007/s10620-004-9579-y
   Web of Science ®Google Scholar
• Monteleone G, Trapasso F, Parrello T, et al. Bioactive IL-18 expression is up-regulated in Crohn’s disease. J Immunol. 1999;163(1):143–147.
   PubMed Web of Science ®Google Scholar
• Bagheri N, Taghikhani A, Rahimian G, et al. Association between virulence factors of helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients. Microb Pathog. 2013;65:7–13. doi:10.1016/j.micpath.2013.08.005
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Salehi F. Evaluation of observed and the expected incidence of common cancers: an experience from Southwestern of Iran, 2010–2014. JResMed. 2018;23:4.
   Google Scholar
• Aghaei A, Ahmadi-Jouibari T, Baiki O, Mosavi-Jarrahi A. Estimation of the gastric cancer incidence in Tehran by two-source capture-recapture. Asian Pac J Cancer Prev. 2013;14(2):673–677. doi:10.7314/APJCP.2013.14.2.673
   Google Scholar
• Almasi Z, Rafiemanesh H, Salehiniya H. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev. 2015;16(7):2757–2761. doi:10.7314/APJCP.2015.16.7.2757
   PubMedGoogle Scholar
• Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. Journal of BU ON. 2016;21(4):994–1004.
   Google Scholar
• Amani F, Ahari SS, Barzegari S, Hassanlouei B, Sadrkabir M, Farzaneh E. Analysis of relationships between altitude and distance from volcano with stomach Cancer incidence using a geographic information system. Asian Pac J Cancer Prev. 2015;16(16):6889–6894. doi:10.7314/APJCP.2015.16.16.6889
   Google Scholar
• Amoori N, Mirzaei M, Cheraghi M. Incidence of cancers in Kuzestan province of iran: trend from 2004 to 2008. Asian Pac J Cancer Prev. 2014;15(19):8345–8349. doi:10.7314/APJCP.2014.15.19.8345
   PubMedGoogle Scholar
• Amori N, Aghajani M, Asgarian F, Jazayeri M. Epidemiology and trend of common cancers in Iran (2004–2008). Eur J Cancer Care. 2017;26(5):e12449. doi:10.1111/ecc.12449
   Web of Science ®Google Scholar
• Eishi Oskuie A. Frequency of cancers and their demographic characteristics in patients referred to omid hospital of Urmia. Int J Trop Med. 2016;11(2):13–20.
   Google Scholar
• Babaei M, Jaafarzadeh H, Sadjadi A, et al. Cancer incidence and mortality in Ardabil: report of an ongoing population-based cancer registry in Iran, 2004-2006. Iran J Public Health. 2009;35–45.
   Web of Science ®Google Scholar
• Babaei M, Mousavi S, Malek M, et al. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2005;159–164.
   Google Scholar
• Jenabi E, Saatchi M, Khazaei S, et al. National distribution of stomach cancer incidence in Iran: a population-based study. Adv Hum Biol. 2019;9(1):89–93. doi:10.4103/AIHB.AIHB_37_18
   Web of Science ®Google Scholar
• Hassanzade J. Incidence and mortality rate of common gastrointestinal cancers in south of Iran, a population based study. Iran J Cancer Prev. 2011;4(4):163.
   Google Scholar
• Chamanpara P, Moghimbeigi A, Faradmal J, Poorolajal J. Joint disease mapping of two digestive cancers in Golestan Province, Iran using a shared component model. Osong Public Health Res Perspect. 2015;6(3):205–210. doi:10.1016/j.phrp.2015.02.002
   Google Scholar
• Haghdoost -A-A, Hosseini H, Chamani G, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–370.
   Web of Science ®Google Scholar
• Haghighi P, Nasr K. Gastrointestinal cancer in Iran. J Chronic Dis. 1971;24(10):625–633. doi:10.1016/0021-9681(71)90065-8
   Google Scholar
• Khodadost M, Yavari P, Babaei M, et al. Estimating the completeness of gastric cancer registration in Ardabil/Iran by a capture-recapture method using population-based cancer registry data. Asian Pac J Cancer Prev. 2015;16(5):1981–1986. doi:10.7314/APJCP.2015.16.5.1981
   PubMedGoogle Scholar
• Alireza S, Mehdi N, Ali M, Alireza M, Reza M, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005;6(3):359.
   Google Scholar
• Khazaei S, Mansori K, Ayubi E, et al. Gender-age disparity of cancers’ incidence in Iran. Acta Medica Iranica. 2018;585–590.
   Google Scholar
• Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing epidemiology of common cancers in Southern Iran, 2007-2010: a cross sectional study. PLoS One. 2016;11(5):e0155669. doi:10.1371/journal.pone.0155669
   Web of Science ®Google Scholar
• Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol. 2011;35(5):e42–e7. doi:10.1016/j.canep.2011.05.018
   PubMed Web of Science ®Google Scholar
• MOHEBI M, NOURI JK, Mahmoudi M, et al. Time of occurrence and age distribution of digestive tract cancers in northern Iran. Iranian J Publ Health. 2008;37(1):8–19.
   Web of Science ®Google Scholar
• Kavousi A, Bashiri Y, Mehrabi Y, Etemad K, Teymourpour A. Identifying high-risk clusters of gastric cancer incidence in Iran, 2004-2009. Asian Pac J Cancer Prev. 2015;15(23):10335–10337. doi:10.7314/APJCP.2014.15.23.10335
   Google Scholar
• Moradpour F, Fatemi Z. Estimation of the projections of the incidence rates, mortality and prevalence due to common cancer site in Isfahan, Iran. Asian Pac J Cancer Prev. 2013;14(6):3581–3585. doi:10.7314/APJCP.2013.14.6.3581
   Google Scholar
• Fateh M, Emamian MH. Cancer incidence and trend analysis in Shahroud, Iran, 2000-2010. Iran J Cancer Prev. 2013;6(2):85.
   Google Scholar
• Fararouei M, Parisai Z, Farahmand M, Haghighi RE, Toori MA. Cancer incidence appears to be rising in a small province in Islamic Republic of Iran: a population-based cohort study. East Mediterr Health J. 2015;21(5):319–325. doi:10.26719/2015.21.5.319
   Web of Science ®Google Scholar
• Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409–1413. doi:10.7314/APJCP.2015.16.4.1409
   PubMedGoogle Scholar
• Faramarzi H, Bagheri P, Farahmandfar M, Lari MA. Cancer occurrence in the south of Iran based upon pathology reports (2001–2009). J. Afr. Cancer. 2013;5(3):137–143. doi:10.1007/s12558-013-0263-z
   Google Scholar
• Mashhadi M, Zakeri Z, Abdollahinejad M. Cancer incidence in South East of Iran: results of a population-based cancer registry. Shiraz E-Med J. 2010;11(3):148–155.
   Google Scholar
• Mohebbi M, Wolfe R, Jolley D, Forbes AB, Mahmoodi M, Burton RC. The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences. Int J Health Geogr. 2011;10(1):13. doi:10.1186/1476-072X-10-13
   Web of Science ®Google Scholar
• Yavari P, Hislop TG, Bajdik C, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006;7(1):86.
   Google Scholar
• Vakili M, Pirdehghan A, Adimi M, Sadeghian M, Akhondi M. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. J Res Health Sci. 2014;14(3):210–213.
   Google Scholar
• Darabi M, Lari MA, Motevalian SA, Motlagh A, Arsang-Jang S, Jaberi MK. Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis. Epidemiol Health. 2016;38:e2016056. doi:10.4178/epih.e2016056
   Google Scholar
• Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S. Cancer incidence in southwest of iran: first report from khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev. 2013;14(12):7517–7522. doi:10.7314/APJCP.2013.14.12.7517
   Google Scholar
• Norouzinia M, Asadzadeh H, Shalmani HM, Al Dulaimi D, Zali M. Clinical and histological indicators of proximal and distal gastric cancer in eight provinces of Iran. Asian Pac J Cancer Prev. 2012;13(11):5677–5679. doi:10.7314/APJCP.2012.13.11.5677
   Google Scholar
• Askarian M, Goli A, Oroei M, Faramarzi H. The geographical clusters of gastrointestinal tract cancer in fars province, southern iran. Int J Prev Med. 2014;5(7):857–864.
   Google Scholar
• Norouzirad R, Khazaei Z, Mousavi M, et al. Epidemiology of common cancers in Dezful county, southwest of Iran. Immunopathol Persa. 2018;4(1):7.
   Web of Science ®Google Scholar
• Najafi F, Mozaffari H, Karami M, Izadi B, Tavvafzadeh R, Pasdar Y. Trends in incidence of gastrointestinal tract cancers in Western Iran, 1993-2007. Iran Red Crescent Med. 2011;13(11):805–810.
   Web of Science ®Google Scholar
• Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2008;20(3):556–563.
   Web of Science ®Google Scholar
• Enayatrad M, Salehiniya H. Trends in gastric cancer incidence in Iran. J Mazandaran Univ Med Sci. 2014;24(114):8–16.
   Google Scholar
• Haidari M, Nikbakht MR, Pasdar Y, Najafi F. Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005. Asian Pac J Cancer Prev. 2012;13(7):3335–3341. doi:10.7314/APJCP.2012.13.7.3335
   Google Scholar
• Marzoni A-SH, Moghimbeigi A, Faradmal J. Gastric and esophageal cancers incidence mapping in golestan province, Iran: using Bayesian–Gibbs sampling. Osong Public Health Res Perspect. 2015;6(2):100–105. doi:10.1016/j.phrp.2015.01.004
   Google Scholar
• Ahmadipanahmehrabadi V, Hassanzadeh A, Mahaki B. Bivariate spatio-temporal shared component modeling: mapping of relative death risk due to colorectal and stomach cancers in Iran provinces. Int J Prev Med. 2019;10:39. doi:10.4103/ijpvm.IJPVM_31_17
   Web of Science ®Google Scholar
• Aghamohammadi S, Kazemi E, Khosravi A, Kazemeini H. The trend of ten leading causes of death in the Islamic Republic of Iran, 2006-2011. IRJE. 2017;12(4):1–11.
   Google Scholar
• Amoori N, Mahdavi S, Enayatrad M. Epidemiology and trend of stomach cancer mortality in Iran. Int J Epidemiol Res. 2016;3(3):268–275.
   Google Scholar
• Khorasani S, Rezaei S, Rashidian H, Daroudi R. Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran. Asian Pac J Cancer Prev. 2015;16(5):1845–1850. doi:10.7314/APJCP.2015.16.5.1845
   PubMedGoogle Scholar
• Nalini M, Oranuba E, Poustchi H, et al. Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran. BMJ Open. 2018;8(7):e021479. doi:10.1136/bmjopen-2018-021479
   Web of Science ®Google Scholar
• Mohammadi G, Akbari ME, Mehrabi Y, Motlagh AG, Heidari M, Ghanbari S. Analysis of cancer incidence and mortality in Iran using joinpoint regression analysis. Iran Red Crescent Med J. 2017;19:3.
   Web of Science ®Google Scholar
• Malekzadeh MM, Khademi H, Pourshams A, et al. Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol. 2013;108(11):1757. doi:10.1038/ajg.2013.336
   Web of Science ®Google Scholar
• Ostadrahimi A, Payahoo L, Somi MH, Khajebishak Y. The association between urinary cadmium levels and dietary habits with risk of gastrointestinal cancer in Tabriz, Northwest of Iran. Biol Trace Elem Res. 2017;175(1):72–78. doi:10.1007/s12011-016-0764-6
   PubMed Web of Science ®Google Scholar
• Islami F, Kamangar F, Aghcheli K, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. British Journal of Cancer. 2004;90(7):1402. doi:10.1038/sj.bjc.6601737
   PubMed Web of Science ®Google Scholar
• Barekat AA, Saidi F, Dutz W. Cancer survey in south Iran with special reference to gastrointestinal neoplasms. Int J Cancer. 1971;7(2):353–363. doi:10.1002/ijc.2910070221
   Web of Science ®Google Scholar
• Bashash M, Yavari P, Hislop TG, et al. Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer. 2011;42(1):40–45. doi:10.1007/s12029-010-9228-y
   Google Scholar
• Pourhoseingholi A, Pourhoseingholi MA, Vahedi M, et al. Relation between demographic factors and type of gastrointestinal cancer using probit and logit regression. Asian Pac J Cancer Prev. 2008;9(4):753–755.
   Google Scholar
• Tabrizchee H, Masoomian M, Ahani F, Zare M. The pattern of malignant Tumors in Kerman province. MJIRI. 1998;12(1):19–23.
   Google Scholar
• Tavoli A, Mohagheghi MA, Montazeri A, Roshan R, Tavoli Z, Omidvari S. Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol. 2007;7(1):28. doi:10.1186/1471-230X-7-28
   PubMed Web of Science ®Google Scholar
• Hajmanoochehri F, Mohammadi N, Nasirian N, Hosseinkhani M. Patho-epidemiological features of esophageal and gastric cancers in an endemic region: a 20-year retrospective study. Asian Pac J Cancer Prev. 2013;14(6):3491–3497. doi:10.7314/APJCP.2013.14.6.3491
   Google Scholar
• Khademloo M, Moosazadeh M, Ahmadi M, Alizadeh-Navaei R. Geographical distribution of gastric cancer in north of Iran—a cross-sectional study. World Cancer Res J. 2018;5(1):e1050.
   Web of Science ®Google Scholar
• Tayebi M, Shabestani Monfared A, Moslemi D. A 10 year survey of cancer in patients who referred to Shahid Rajai Radiotherapy Center in North of Iran (2000-2009). J BU MS. 2012;14(6):97–101.
   Google Scholar
• Nikfarjam Z, Massoudi T, Salehi M, Salehi M, Khoshroo F. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades. Asian Pac J Cancer Prev. 2014;15(23):10193–10198. doi:10.7314/APJCP.2014.15.23.10193
   Google Scholar
• Hashemi SM, Mashhadi M, Moghaddam AA, et al. The relationship between serum selenium and zinc with gastroesophageal cancers in the Southeast of Iran. Indian J Med Paediatr Oncol. 2017;38(2):169.
   Web of Science ®Google Scholar
• Yazdizadeh B, Jarrahi A, Mortazavi H, Mohagheghi MA, Tahmasebi S, Nahvijo A. Time trends in the occurrence of major GI cancers in Iran. Asian Pac J Cancer Prev. 2005;6(2):130–134.
   Google Scholar
• Mehrabian A, Esna-Ashari F, Zham H, et al. Gastric cancer prevalence, according to survival data in Iran (National Study-2007). IranJ Public Health. 2010;39(3):27–31.
   Web of Science ®Google Scholar
• Kadivar M, Rahimabad PK. Missing elements in surgical pathology reports: breast, Colon and Stomach Cancers. Asian Pac J Cancer Prev. 2016;17(3):1469–1472. doi:10.7314/APJCP.2016.17.3.1469
   Google Scholar
• Karami K, Cheraghi M, Amori N, Pedram M, Sobhani A. Common cancers in Khuzestan province, south west of Iran, during 2005-2011. Asian Pac J Cancer Prev. 2014;15(21):9475–9478. doi:10.7314/APJCP.2014.15.21.9475
   Google Scholar
• Boreiri M, Samadi F, Etemadi A, et al. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Arch IranMed. 2013;16(6):343–347.
   PubMed Web of Science ®Google Scholar
• Moghimi-Dehkordi B, Safaee A, Vahedi M, et al. Familial prevalence of cancer in Iran: a general population estimate. Asian Pac J Cancer Prev. 2011;12(1):289–295.
   Google Scholar
• Zendehdel N, MASARAT S, SHEYKH AA, et al. Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients. Arch Iran Med. 2010;13(6):469–475.
   Web of Science ®Google Scholar
• Ahmadi K, Soleimani A, Irani S, et al. DNMT3B− 579 G> T promoter polymorphism and the risk of gastric cancer in the West of Iran. J Gastrointest Cancer. 2018;49(2):167–171. doi:10.1007/s12029-017-9928-7
   PubMed Web of Science ®Google Scholar
• Azarbarzin S, Safaralizadeh R, Kazemzadeh M, Fateh A. The value of MiR-383, an intronic MiRNA, as a diagnostic and prognostic biomarker in intestinal-type gastric cancer. Biochem Genet. 2017;55(3):244–252. doi:10.1007/s10528-017-9793-x
   PubMed Web of Science ®Google Scholar
• Azarkhazin F, Tehrani GA. Detecting promoter methylation pattern of apoptotic genes Apaf1 and Caspase8 in gastric carcinoma patients undergoing chemotherapy. J GastrointestOncol. 2018;9(2):295–302.
   Google Scholar
• Azarhoush R, KESHTKAR AA, AMIRIAN T, KAZEMINEZHAD. Relationship Between P53 Expression and Gastric Cancers in Cardia and Antrum. Arch Iran Med. 2008;11(5):502–506.
   Google Scholar
• Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer. 2011;128(11):2645–2652. doi:10.1002/ijc.25643
   Web of Science ®Google Scholar
• Ismaili A, Yari K, Moradi M-T, et al. IL-1B (C+ 3954T) gene polymorphism and susceptibility to gastric cancer in the Iranian population. Asian Pac J Cancer Prev. 2015;16:841–844. doi:10.7314/APJCP.2015.16.2.841
   Google Scholar
• Aghdam SM, Sardari Z, Safaralizadeh R, et al. Investigation of association between oipA and iceA1/iceA2 genotypes of Helicobacter pylori and gastric cancer in Iran. Asian Pac J Cancer Prev. 2014;15(19):8295–8299. doi:10.7314/APJCP.2014.15.19.8295
   Google Scholar
• Akrami H, Mahmoodi F, Havasi S, Sharifi A. PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3K/Akt and p38MAPK pathways. Cell Biochem Funct. 2016;34(3):173–180. doi:10.1002/cbf.3176
   Web of Science ®Google Scholar
• Amoueian S, Attaranzadeh A, Montazer M. Intratumoral CD68-, CD117-, CD56-, and CD1a-positive immune cells and the survival of Iranian patients with non-metastatic intestinal-type gastric carcinoma. Pathol Res Pract. 2015;211(4):326–331. doi:10.1016/j.prp.2014.12.013
   Web of Science ®Google Scholar
• Amini M, Foroughi K, Talebi F, et al. GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond. J Cell Physiol. 2019;1–10.
   Web of Science ®Google Scholar
• Iranpour M, Nourian M, Saffari S, et al. PIK3CA mutation analysis in iranian patients with gastric cancer. Iran Biomed J. 2019;23(1):87–91. doi:10.29252/ibj.23.1.87
   PubMedGoogle Scholar
• Ayremlou N, Mozdarani H, Mowla SJ, Delavari A. Increased levels of serum and tissue miR-107 in human gastric cancer: correlation with tumor hypoxia. Cancer Biomark. 2015;15(6):851–860. doi:10.3233/CBM-150529
   PubMed Web of Science ®Google Scholar
• Basi A, Raoofi A, Vaseghi H, Zare-Mehrjardi A. Study of HER2 expression and its relation to tumor characteristics among gastric adenocarcinoma patients of Firoozgar hospital, Tehran, Iran; in 2010 and 2011. Int J Hematol Oncol Stem Cell Res. 2012;6(4):25–29.
   Google Scholar
• Bagheri V, Abbaszadegan MR, Memar B, et al. Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer. Life Sci. 2019;219:136–143. doi:10.1016/j.lfs.2019.01.016
   Web of Science ®Google Scholar
• Bagheri N, Azadegan-Dehkordi F, Sanei H, et al. Associations of a TLR4 single-nucleotide polymorphism with H. ápylori associated gastric diseases in iranian patients. Clin Res Hepatol Gastroenterol. 2014;38(3):366–371. doi:10.1016/j.clinre.2013.12.004
   Web of Science ®Google Scholar
• Bagheri N, Sadeghiani M, Rahimian G, et al. Correlation between expression of MMP-9 and MMP-3 in Helicobacter pylori infected patients with different gastroduodenal diseases. Arab J Gastroenterol. 2018;19(4):148–154. doi:10.1016/j.ajg.2018.11.001
   Web of Science ®Google Scholar
• Basati G, Mohammadpour H, Emami-Razavi A. Low expression levels of peroxisome proliferator-activated receptor gamma (PPARγ) in gastric cancer and its relationship with tumor progression. J Isfahan Med Sch. 2017;35(440):911–918.
   Google Scholar
• Basiri Z, Safaralizadeh R, Bonyadi MJ, Somi MH, Mahdavi M, Latifi-Navid S. Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in northwestern Iran. Asian Pac J Cancer Prev. 2014;15(4):1575–1579. doi:10.7314/APJCP.2014.15.4.1575
   Google Scholar
• Bahadori A, Somi MH, Doran F, et al. Determination of correlation between principal genotypes of Helicobacter pylori according to cagPAI components and vacA genotypes and clinical out come in patients suffering from active chronic gastritis and gastric adenocarcinoma from Iran and Turkey. Biomed Res. 2017;28(4):1743–1748.
   Google Scholar
• Bahadori A, SOMI MH, Doran F, et al. Comparative analysis of selected cagPAI genes and different vacA genotypes in Iranian and Turkish H. pylori-positive patients suffering from gastric adenocarcinoma and active chronic gastritis. . Turk J Med Sci. 2017;47(3):916–922.
   Web of Science ®Google Scholar
• Bahari F, Emadi-Baygi M, Nikpour P. miR-17-92 host gene, underexpressed in gastric cancer and its expression was negatively correlated with the metastasis. Indian J Cancer. 2015;52(1):22. doi:10.4103/0019-509X.175605
   Web of Science ®Google Scholar
• Beheshtizadeh M, Moslemi E. Analysis of G3BP1 and VEZT expression in gastric cancer and their possible correlation with tumor clinicopathological factors. Journal of Gastric Cancer. 2017;17(1):43–51. doi:10.5230/jgc.2017.17.e5
   Web of Science ®Google Scholar
• Bohlooli S, Jafari N, Jahed S. Cytotoxic effect of freeze-dried extract of Ecballium elaterium fruit on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cell lines. J Gastrointest Cancer. 2012;43(4):579–583. doi:10.1007/s12029-012-9383-4
   Google Scholar
• Baygi ME, Nikpour P. Deregulation of MTDH gene expression in gastric cancer. Asian Pac J Cancer Prev. 2012;13(6):2833–2836. doi:10.7314/APJCP.2012.13.6.2833
   Google Scholar
• Savabkar S, Azimzadeh P, Chaleshi V, Mojarad EN, Aghdaei HA. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer. Gastroenterol Hepatol Bed Bench. 2013;6(4):178–182.
   PubMedGoogle Scholar
• Janbabai G, Oladi Z, Farazmandfar T, Taghvaei T, Naghshvar F. The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR. J Cancer Res Clin Oncol. 2015;141(11):1945–1952. doi:10.1007/s00432-015-1965-7
   Web of Science ®Google Scholar
• Jafargholizadeh N, Zargar SJ, Aftabi Y. The cucurbitacins D, E, and I from Ecballium elaterium (L.) upregulate the LC3 gene and induce cell-cycle arrest in human gastric cancer cell line AGS. Iran J Basic Med Sci. 2018;21(3):253.
   Web of Science ®Google Scholar
• Jafari F, Shokrzadeh L, Dabiri H, et al. vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis. 2008;61(4):290–293.
   PubMed Web of Science ®Google Scholar
• Javanbakht M, Akhavanmoghadam J, Talaei AJ, et al. Differential expression of two genes Oct‐4 and MUC 5 AC associates with poor outcome in patients with gastric cancer. Clin Exp Pharmacol Physiol. 2017;44(11):1099–1105. doi:10.1111/1440-1681.12840
   Web of Science ®Google Scholar
• Jeivad F, Abediankenari S, Shokrzadeh M, et al. Tyrosine kinase domain gene polymorphism of epidermal growth factor receptor in gastric cancer in northern Iran. Tehran Univ Med J. 2012;69(10):619–623.
   Google Scholar
• Cherati MR, Shokri-Shirvani J, Karkhah A, Rajabnia R, Nouri HR. Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran. Microb Pathog. 2017;107:413–418. doi:10.1016/j.micpath.2017.04.025
   PubMed Web of Science ®Google Scholar
• Hafezi N, Ajami A, Farazmandfar T, Hosseini V, ALIZADEH NR, Tehrani M. Increased expression of two alternative spliced variants of CD1d molecule in human gastric cancer. Iran J Immunol. 2015;12(2):129–140.
   PubMed Web of Science ®Google Scholar
• Habibzadeh M, Tourani M, Shokri-Shirvani J, Mostafazadeh A, Khafri S, Nouri HR. TLR2 Arg677Trp but not TLR2-196 to-174 ins/del and Arg753Gln polymorphism alter the risk of peptic ulcer in north of Iran. J Chin Med Assoc. 2018;81(1):25–30. doi:10.1016/j.jcma.2017.05.009
   PubMed Web of Science ®Google Scholar
• Habibi A, Ranjbari N, Rahim F, Jazayeri N. Correlation between CD34 Marker and clinico-pathologic characteristics of gastric cancer. Cancer Res. 2015;11(3):136–142.
   Google Scholar
• Hosseinzadeh A, Ardebili SMM. Efficacy of omega fatty acid supplementation on mRNA expression level of tumor necrosis factor alpha in patients with gastric adenocarcinoma. J Gastrointest Cancer. 2016;47(3):287–293. doi:10.1007/s12029-016-9826-4
   Google Scholar
• Hussein N. The association of dupA and Helicobacter pylori-related gastroduodenal diseases. Eur J Clin Microbiol Infect Dis. 2010;29(7):817–821. doi:10.1007/s10096-010-0933-z
   PubMed Web of Science ®Google Scholar
• Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi‐Firozi M, Farjadian S, Ghaderi A. IL‐18 serum level and IL‐18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol. 2009;24(6):1119–1122.
   Web of Science ®Google Scholar
• Heidari K, Nezhad VK, Noroozi A, Mehravar F. The Prevalence of Helicobacter pylori Virulence Related Genes (hpa and babA2) in Iranian patients with gastrointestinal disorders. Jundishapur J Microbiol. 2017;10:12. doi:10.5812/jjm.60947
   Web of Science ®Google Scholar
• Heydari-Mehrabadi A, Tamandani DMK, Baranzehi T, Hemati S. Analysis of polymorphism and expression profile of ASIC1 and IL-6 genes in patients with gastric cancer. Asian Pac J Cancer Preve. 2018;19(12):3451–3455. doi:10.31557/APJCP.2018.19.12.3451
   Google Scholar
• Khatami F, Noorinayer B, Ghiasi S, Mohebi R, Hashemi M, Zali MR. Lack of effects of single nucleotide polymorphisms of the DNA methyltransferase 1 gene on gastric cancer in Iranian patients: a case control study. Asian Pac J Cancer Prev. 2009;10(6):1177–1182.
   PubMedGoogle Scholar
• Khaleghian M, Shakoori A, Razavi AE, Azimi C. Relationship of amplification and expression of the C-MYC gene with survival among gastric cancer patients. Asian Pac J Cancer Prev. 2015;16(16):7061–7069. doi:10.7314/APJCP.2015.16.16.7061
   Google Scholar
• Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the genes involved in reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in gastric adenocarcinoma. J Gastrointest Cancer. 2015;46(3):251–258. doi:10.1007/s12029-015-9695-2
   Google Scholar
• Khalili M, Sadeghizadeh M, Ghorbanian K, Malekzadeh R, Vasei M, Mowla SJ. Down-regulation of miR-302b, an ESC-specific microRNA, in gastric adenocarcinoma. Cell J. 2012;13(4):251–258.
   PubMed Web of Science ®Google Scholar
• Daneshpour M, Karimi B, Omidfar K. Simultaneous detection of gastric cancer-involved miR-106a and let-7a through a dual-signal-marked electrochemical nanobiosensor. Biosens Bioelectron. 2018;109:197–205. doi:10.1016/j.bios.2018.03.022
   Web of Science ®Google Scholar
• Salehi Z, Akrami H. Target genes prediction and functional analysis of microRNAs differentially expressed in gastric cancer stem cells MKN-45. J Cancer Res Ther. 2017;13(3):477–483.
   Web of Science ®Google Scholar
• Sabahi Z, Salek R, Heravi R, Mosaffa F, Avanaki Z, Behravan J. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer. 2010;47(3):317–321. doi:10.4103/0019-509X.64723
   Web of Science ®Google Scholar
• Sedarat Z, Khashei R, Shirzad H, et al. Frequency of helicobacter pylori hopQI, hopQII and sabA genes among Iranian patients with gastroduodenal diseases. Jundishapur J Microbiol. 2018;11(8):e56017. doi:10.5812/jjm.56017
   Web of Science ®Google Scholar
• Souod N, Kargar M, Doosti A, Ranjbar R, Sarshar M. Genetic analysis of cagA and vacA genes in Helicobacter pylori isolates and their relationship with gastroduodenal diseases in the west of Iran. Iran Red Crescent Med J. 2013;15(5):371–375. doi:10.5812/ircmj.3732
   PubMed Web of Science ®Google Scholar
• Safaralizadeh R, Ajami N, Nemati M, Hosseinpourfeizi M, Isfanjani AA, Moaddab S-Y. Disregulation of miR-216a and miR-217 in gastric cancer and their clinical significance. J Gastrointest Cancer. 2019;50(1):78–83. doi:10.1007/s12029-017-0019-6
   PubMed Web of Science ®Google Scholar
• Abadi ATB, Rafiei A, Ajami A, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol. 2011;49(9):3191–3197.
   Web of Science ®Google Scholar
• Abadi ATB, Taghvaei T, Wolfram L, Kusters JG. Infection with Helicobacter pylori strains lacking dupA is associated with an increased risk of gastric ulcer and gastric cancer development. J Med Microbiol. 2012;61(1):23–30. doi:10.1099/jmm.0.027052-0
   Web of Science ®Google Scholar
• Abadi ATB, Taghvaei T, Mobarez AM, Vaira G, Vaira D. High correlation of babA 2-positive strains of Helicobacter pylori with the presence of gastric cancer. Intern Emerg Med. 2013;8(6):497–501. doi:10.1007/s11739-011-0631-6
   Web of Science ®Google Scholar
• Abediankenari S, Jeivad F. Epidermal growth factor receptor gene polymorphisms and gastric cancer in Iran. Asian Pac J Cancer Prev. 2013;14(5):3187–3190. doi:10.7314/APJCP.2013.14.5.3187
   Google Scholar
• Abdi E, Latifi-Navid S, Yazdanbod A, Zahri S. Helicobacter pylori babA2 positivity predicts risk of gastric cancer in Ardabil, a very high-risk area in Iran. Asian Pac J Cancer Prev. 2016;17(2):733–738. doi:10.7314/APJCP.2016.17.2.733
   Google Scholar
• Ezzeddini R, Taghikhani M, Somi MH, Samadi N, Rasaee MJ. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. Life Sci. 2019;224:169–176. doi:10.1016/j.lfs.2019.03.056
   PubMed Web of Science ®Google Scholar
• Effatpanah H, Yadegarazari R, Karami M, Majlesi A, Shabab N, Saidijam M. Expression analysis of mir-21 and mir-221 in cancerous tissues from Iranian patients with gastric cancer. Iran Biomed J. 2015;19(4):188–193.
   Google Scholar
• Oghalaie A, Saberi S, Esmaeili M, et al. Helicobacter pylori peptidyl prolyl isomerase expression is associated with the severity of gastritis. J Gastrointest Cancer. 2016;47(4):375–380. doi:10.1007/s12029-016-9849-x
   Google Scholar
• Dabiri H, Jafari F, Baghaei K, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microb Pathog. 2017;105:226–230. doi:10.1016/j.micpath.2017.02.018
   PubMed Web of Science ®Google Scholar
• Alghalandis LD, Shahsavani R, Ghavamzadeh A, et al. Development of a quantitative Real-Time PCR for micrometastasis detection using CEA in peripheral blood and bone marrow specimens of gastric cancer patients. Tehran Univ Med J. 2009;67(8):542–548.
   Google Scholar
• Dardaei L, Shahsavani R, Ghavamzadeh A, et al. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR. Clinical Chemists. 2011;44(4):325–330.
   Google Scholar
• Dastjerdi MN, Kavoosi F, Valiani A, et al. Inhibitory effect of genistein on PLC/PRF5 hepatocellular carcinoma cell line. Int J PrevMed. 2015;6:54. doi:10.4103/2008-7802.158914
   Google Scholar
• Douraghi M, Talebkhan Y, Zeraati H, et al. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion. 2009;80(3):200–207. doi:10.1159/000229774
   Web of Science ®Google Scholar
• Razmkhah M, Ghaderi A. SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers. Indian J Gastroenterol. 2013;32(1):28–31. doi:10.1007/s12664-012-0283-0
   Google Scholar
• Rostami M, Kalaei Z, Pourhoseingholi MA, Kadivar M. Study on association between H-ras gene polymorphism and gastric adenocarcinoma risk. Gastroenterol Hepatol Bed Bench. 2013;6(3):146–151.
   Google Scholar
• Zare A, Ahadi A, Larki P, et al. The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer. Mol Biol Rep. 2018;45(6):1587–1595. doi:10.1007/s11033-018-4278-5
   Web of Science ®Google Scholar
• Zare A, Alipoor B, Omrani MD, Zali MR, Alamdari NM, Ghaedi H. Decreased miR-155-5p, miR-15a, and miR-186 expression in gastric cancer is associated with advanced tumor grade and metastasis. Iran Biomed J. 2019;23(5):338. doi:10.29252/ibj.23.5.5
   Google Scholar
• Zandi S, Hedayati MA, Mohammadi E, Sheikhesmaeili F. Helicobacter pylori infection increases sirt2 gene expression in gastric epithelial cells of gastritis patients. Microb Pathog. 2018;116:120–123. doi:10.1016/j.micpath.2017.12.078
   Web of Science ®Google Scholar
• Sadjadi A, Yazdanbod A, Lee YY, et al. Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. PLoS One. 2013;8(9):e74440. doi:10.1371/journal.pone.0074440
   Web of Science ®Google Scholar
• Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169(1):21–26. doi:10.1016/S0304-3835(01)00550-X
   PubMed Web of Science ®Google Scholar
• Soleimani A, Ghanadi K, Noormohammadi Z, Irani S. The correlation between miR‐146a C/G polymorphism and UHRF1 gene expression level in gastric tumor. J Dig Dis. 2016;17(3):169–174. doi:10.1111/1751-2980.12329
   Web of Science ®Google Scholar
• Sohrabi S, Effatpanah H, Shabab N, Saidijam M. Expression analysis of PTEN and CDKN1C/p57kip2 in cancerous tissues from Iranian patients with gastric cancer. Eur J Oncol. 2017;22(2):88–94.
   Google Scholar
• Shahhoseini Z, Jeivad F, Ahangar N, Abediankenari S. Different genotype of rs3130932 single nucleotide polymorphism between gastric cancer patients and normal subjects. J Gastrointest Cancer. 2017;48(1):38–41. doi:10.1007/s12029-016-9869-6
   Web of Science ®Google Scholar
• Saberi S, Zendehdel K, Jahangiri S, et al. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. IranBiomed J. 2012;16(4):179–184.
   Google Scholar
• Imani-Saber Z, Yousefi-Razin E, Javaheri M, Mirfakhraie R, Motalleb G, Ghafouri-Fard S. Promyelocytic leukemia (PML) gene mutations may not contribute to gastric adenocarcinoma development. Asian Pac J Cancer Prev. 2015;16(8):3523–3525. doi:10.7314/APJCP.2015.16.8.3523
   Google Scholar
• Masoudi M, Saadat I, Omidvari S, Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2009;36(4):781–784. doi:10.1007/s11033-008-9245-0
   Web of Science ®Google Scholar
• Moghanibashi M, Mohamadynejad P, Rasekhi M, Ghaderi A, Mohammadianpanah M. Polymorphism of estrogen response element in TFF1 gene promoter is associated with an increased susceptibility to gastric cancer. Gene. 2012;492(1):100–103. doi:10.1016/j.gene.2011.10.048
   Web of Science ®Google Scholar
• Moghbeli M, Moaven O, Memar B, et al. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J Gastrointest Cancer. 2014;45(1):40–47. doi:10.1007/s12029-013-9548-9
   Google Scholar
• Moghbeli M, Makhdoumi Y, Delgosha MS, et al. ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer. Biol Res. 2019;52(1):2. doi:10.1186/s40659-018-0208-1
   Web of Science ®Google Scholar
• Mokmeli S, Tehrani GA, Zamiri RE, Bahrami T. Investigating the frequency of the ERCC1 Gene C8092A polymorphism in Iranian patients with advanced gastric cancer. Asian Pac J Cancer Prev. 2016;17(3):1369–1372. doi:10.7314/APJCP.2016.17.3.1369
   Google Scholar
• Malek-Hosseini Z, Taherinejad M, Malekzadeh M, Ghaderi A, Doroudchi M. IL-17A levels in the sera of patients with gastric cancer show limited elevation. Asian Pac J Cancer Prev. 2015;16:7149–7153. doi:10.7314/APJCP.2015.16.16.7149
   Google Scholar
• Mansoori M, Golalipour M, Alizadeh S, et al. Genetic Variation in the ABCB1 gene may lead to mRNA level change: application to gastric cancer cases. Asian Pac J Cancer Prev. 2015;16(18):8467–8471. doi:10.7314/APJCP.2015.16.18.8467
   Google Scholar
• Mirmajidi SH, Ataee R, Barzegar A, Nikbakhsh N, Shaterpour M. Low Expression of the bcl2 Gene in Gastric Adenocarcinomas in Mazandaran Province of Iran. Asian Pac J Cancer Prev. 2015;16(14):6067–6071. doi:10.7314/APJCP.2015.16.14.6067
   Google Scholar
• Sadeghi RN, Azimzadeh P, Vahedi M, et al. Profile and frequency of p53 gene alterations in gastritis lesions from Iran. Digestion. 2011;83(1–2):65–75. doi:10.1159/000320690
   Web of Science ®Google Scholar
• Najafzadeh N, Mazani M, Abbasi A, Farassati F, Amani M. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44+ cancer stem cells. Biomed Pharmacother. 2015;74(243–51.4):243–251. doi:10.1016/j.biopha.2015.08.019
   Web of Science ®Google Scholar
• Norollahi SE, Alipour M, Rashidy-Pour A, Samadani AA, Larijani LV. Regulatory fluctuation of WNT16 gene expression is associated with human gastric adenocarcinoma. J Gastrointest Cancer. 2019;50(1):42–47. doi:10.1007/s12029-017-0022-y
   Web of Science ®Google Scholar
• Noormohammad M, Sadeghi S, Tabatabaeian H, et al. Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. J Genet. 2016;95(4):991–995. doi:10.1007/s12041-016-0728-9
   Web of Science ®Google Scholar
• Nikpour P, Emadi-Baygi M, Mohhamad-Hashem F, Maracy MR, Haghjooy-Javanmard S. MSI1 overexpression in diffuse type of gastric cancer. Pathol Res Pract. 2013;209(1):10–13. doi:10.1016/j.prp.2012.09.008
   Web of Science ®Google Scholar
• Nikpour P, Emadi-Baygi M, Emadi-Andani E, Rahmati S. EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study. Med Oncol. 2014;31(5):955. doi:10.1007/s12032-014-0955-y
   Web of Science ®Google Scholar
• Nikpour P, Emadi-Baygi M, Mohammad-Hashem F, Maracy MR, Haghjooy-Javanmard S. Differential expression of ZFX gene in gastric cancer. J Biosci. 2012;37(1):85–90. doi:10.1007/s12038-011-9174-2
   Web of Science ®Google Scholar
• Hajjari M, Behmanesh M, Sadeghizadeh M, Zeinoddini M. Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med Oncol. 2013;30(3):670. doi:10.1007/s12032-013-0670-0
   Web of Science ®Google Scholar
• Hedayatizadeh‑Omran A, Alizadeh‑Navaei R, Janbabaei G, et al. Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high‑risk region. Biomed Rep. 2018;8(5):433–438.
   Web of Science ®Google Scholar
• Hadinia A, Hossieni SV, Erfani N, Saberi‐Firozi M, Fattahi MJ, Ghaderi A. CTLA‐4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. JGH Open. 2007;22(12):2283–2287.
   Google Scholar
• Andalib A, Doulabi H, Maracy MR, Rezaei A, Hasheminia SJ. CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients. Adv Biomed Res. 2013;2:31. doi:10.4103/2277-9175.108770
   Google Scholar
• Farahani RK, Azimzadeh P, Rostami E, et al. Evaluation of insulin like growth factor-1 genetic polymorphism with gastric cancer susceptibility and clinicopathological features. Asian Pac J Cancer Prev. 2015;16(10):4215–4218. doi:10.7314/APJCP.2015.16.10.4215
   Google Scholar
• Farjadian S, Tabebordbar M, Mokhtari M, Safaei A, Malekzadeh M, Ghaderi AHLA-G. Expression in tumor tissues and soluble HLA-G plasma levels in patients with gastrointestinal cancer. Asian Pac J Cancer Prev. 2018;19(10):2731.
   Google Scholar
• Hemati M, Mansourabadi AH, Bafghi MK, Moradi A. Association between paraoxonase-1 gene Q192R and L55M polymorphisms and risk of gastric cancer: A case-control study from Iran. Nucleosides Nucleotides Nucleic Acids. 2019;38(7):521–532. doi:10.1080/15257770.2019.1573371
   PubMed Web of Science ®Google Scholar
• Honarmand-Jahromy S, Siavoshi F, Malekzadeh R, Sattari TN, Latifi-Navid S. Multiple repeats of Helicobacter pylori CagA EPIYA-C phosphorylation sites predict risk of gastric ulcer in Iran. Microb Pathog. 2015;89:87–92. doi:10.1016/j.micpath.2015.09.005
   Web of Science ®Google Scholar
• Latifi-Navid S, Mohammadi S, Maleki P, et al. Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran. Arch IranMed. 2013;16(6):330–337.
   Web of Science ®Google Scholar
• Mottaghi B, Safaralizadeh R, Bonyadi M, Latifi-Navid S, Somi MH. Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran. Clin Exp Med. 2016;16(1):57–63. doi:10.1007/s10238-014-0327-0
   Web of Science ®Google Scholar
• Motovali-Bashi M, Hamidy M. Association between GT-repeat polymorphism at heme oxygenase-1 gene promoter and gastric cancer and metastasis. Tumour Biol. 2015;36(6):4757–4762. doi:10.1007/s13277-015-3125-8
   Google Scholar
• Mojtahedi Z, Haghshenas M, Hosseini S, Fattahi M, Ghaderi A. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J Cancer. 2010;47(1):31–34. doi:10.4103/0019-509X.58856
   PubMed Web of Science ®Google Scholar
• Mohsenzadeh M, Sadeghi RN, Vahedi M, et al. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: association with histological type and clinical outcomes. Cancer Biomark. 2017;20(1):7–15. doi:10.3233/CBM-160331
   Web of Science ®Google Scholar
• Mohammadi S, Mohamadynejad P, Moghanibashi M. Increased risk of gastric cancer with VNTR polymorphism of SIRT3 Gene. J Mazandaran Univ Med Sci. 2017;27(152):23–30.
   Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Mofarrah M, Dastani-Habashi M, Zarghami N. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. Artif Cells Nanomed Biotechnol. 2016;44(8):1972–1978. doi:10.3109/21691401.2015.1129615
   PubMed Web of Science ®Google Scholar
• Mohamadkhani A, Moghaddam SD, Salmanroghani H, et al. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence? Arch Iranian Med. 2013;16(4):208–212.
   Web of Science ®Google Scholar
• Mohammadi M, Zarghami N, Hedayati M, Ghaemmaghami S, Yamchi R, Mohaddes M. Visfatin effects on telomerase gene expression in AGS gastric cancer cell line. Indian J Cancer. 2015;52(1):32–35. doi:10.4103/0019-509X.175567
   Web of Science ®Google Scholar
• Madani S-H, Rahmati A, Sadeghi E, et al. Survey of Her2-neu expression and its correlation with histology of gastric carcinoma and gastroesophageal junction adenocarcinoma. Asian Pac J Cancer Prev. 2015;16(17):7755–7758. doi:10.7314/APJCP.2015.16.17.7755
   Google Scholar
• Moradi M-T, Salehi Z, Aminian K, Yazdanbod A. Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population. Asian Pac J Cancer Prev. 2014;15(17):7413–7417. doi:10.7314/APJCP.2014.15.17.7413
   Google Scholar
• Moradi M-T, Yari K, Rahimi Z, Kazemi E, Shahbazi M. Manganese superoxide dismutase (MnSOD Val-9Ala) gene polymorphism and susceptibility to gastric cancer. Asian Pac J Cancer Prev. 2015;16(2):485–488. doi:10.7314/APJCP.2015.16.2.485
   Google Scholar
• Moradi M-T, Yari K, Rahimi Z. The GPX1 Pro 198 Leu polymorphism in gastric cancer patients with and without Helicobacter pylori infection. Genes Genomics. 2017;39(11):1265–1269. doi:10.1007/s13258-017-0594-8
   Web of Science ®Google Scholar
• Ghaedi H, Mozaffari MAN, Salehi Z, et al. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Gene. 2019;687:135–142. doi:10.1016/j.gene.2018.11.034
   Web of Science ®Google Scholar
• Ghalandary M, Behmanesh M, Sadeghizadeh M. Evaluating of suppressor of zeste 12 and chromobox homolog 8 genes expression showed two possible origins for gastric cancer development. Indian J Cancer. 2015;52(1):27–31. doi:10.4103/0019-509X.175566
   Web of Science ®Google Scholar
• Kashfi SMH, Farahbakhsh FB, Mojarad EN, et al. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer. Tumour Biol. 2016;37(2):2119–2126. doi:10.1007/s13277-015-4013-y
   Google Scholar
• Kordi Tamandani DM, Hemati S, Davani SK, Arbabi F. Association between promoter methylation and expression of thyroid hormone receptor beta (THR β) gene in patients with gastric cancer in an Iranian population. J Gastroenterol Hepatol. 2015;30(3):485–489. doi:10.1111/jgh.12808
   Web of Science ®Google Scholar
• Kalantari E, Asadi Lari MH, Roudi R, Korourian A, Madjd Z. Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. Biomark Cancer. 2017;20(4):563–573. doi:10.3233/CBM-170383
   Google Scholar
• Kamalidehghan B, Houshmand M, Panahi MSS, Abbaszadegan MR, Ismail P, Shiroudi MB. Tumoral Cell mtDNA∼ 8.9 kb deletion is more common than other deletions in gastric cancer. Arch Med Res. 2006;37(7):848–853. doi:10.1016/j.arcmed.2006.03.007
   Web of Science ®Google Scholar
• Kiani S, Akhavan-Niaki H, Fattahi S, et al. Purified sulforaphane from broccoli (Brassica oleracea var Italica) leads to alterations of CDX1 and CDX2 expression and changes in Mir-9 and Mir-326 levels in human gastric cancer cells. Gene. 2018;678:115–123.
   PubMed Web of Science ®Google Scholar
• Larki P, Ahadi A. Up-regulation of miR-21, miR-25, miR-93, and miR-106b in gastric cancer. Iran Biomed J. 2018;22(6):367–373. doi:10.29252/.22.6.367
   Google Scholar
• Amiri RM, Tehrani M, Taghizadeh S, Shokri-Shirvani J, Fakheri H, Ajami A. Association of nucleotide-binding oligomerization domain receptors with peptic ulcer and gastric cancer. Iran J Allergy Asthma Immunol. 2016;15(5):355–362.
   Web of Science ®Google Scholar
• Mirmajidi SH, Najafi M, Mirmajidi ST, Nasrabadi NN. Study of regulatory promoter polymorphism (-248 G> A) of Bax gene in patients with gastric cancer in the northern provinces of Iran. Gastroenterol Hepatol Bed Bench. 2016;9(1):36–44.
   Google Scholar
• Kordi-Tamandani DM, Davani SK, Baranzehi T, Hemati S. Analysis of promoter methylation, polymorphism and expression profile of cytotoxic T-lymphocyte-associated antigen-4 in patients with gastric cancer. J Gastrointestina Liver Dis. 2014;23(3):249–253. doi:10.15403/jgld.2014.1121.233.dmkt
   Web of Science ®Google Scholar